Related Experiment Video
Updated: May 21, 2026

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery
Published on: June 23, 2011
Specific anti-gp41 antibodies predict HIV-1 disease progression
Vincent Vieillard1, Joël Crouzet, Faroudy Boufassa
1INSERM Laboratory of Immunity and Infection, UMR-S 945, University Pierre et Marie Curie, Paris, France. vincent.vieillard@upmc.fr
Abstract:
The immunodeficiency-defining AIDS results from a progressive decline of CD4 cell count. We previously showed that 3S, a unique motif of the HIV-1 gp41 envelop protein, is highly conserved in HIV-1 strains and induces expression of NKp44L, rendering CD4 cells sensitive to NK killing. Here we found from a well-characterized cohort of 244 untreated HIV-1 seroconverters that high levels of anti-3S antibodies significantly delay spontaneous disease progression in the first years after seroconversion; this effect was not mediated through baseline viral load or CD4. These results could have important implications both for clinical care and better understanding of pathogenicity.

